Skip to main content
. Author manuscript; available in PMC: 2018 Sep 15.
Published in final edited form as: J Neurol Sci. 2017 Jun 29;380:11–15. doi: 10.1016/j.jns.2017.06.044

Table 1.

Clinical Characteristics in Cases of Posterior Reversible Encephalopathy Syndrome, Stratified by Steroid Exposure

Characteristica No Steroids (N=55) Current Steroids (N=44) P
Age, mean (SD), y 50.4 (21.6) 45.1 (22.0) 0.23
Female 43 (78%) 31 (71%) 0.38
Hypertension 24 (44%) 11 (32%) 0.79
Chronic kidney disease 12 (22%) 6 (14%) 0.29
Active cancer 27 (49%) 32 (73%) 0.02
Active chemotherapyb 25 (46%) 33 (75%) <0.01
Autoimmune disease 4 (7%) 10 (23%) 0.04
Active immunosuppressionb 3 (6%) 18 (41%) <0.01
History of brain radiation 2 (4%) (16%) 0.07
Status post bone marrow transplantation 3 (6%) 16 (36%) <0.01
Peripartum 8 (15%) 0 (0) 0.01
Active sepsis 11 (20%) 16 (36%) 0.11
Peak systolic blood pressure, mean (SD), mm Hg 184.5 (35.1) 174.5 (27.0) 0.12
Serum creatinine, mean (SD), mg/dL 1.7 (2.0) 1.6 (2.0) 0.89
Serum sodium, mean (SD), mmol/L 138.1 (4.4) 137.7 (4.2) 0.65
Serum albuminc, mean (SD), g/dL 3.1 (0.8) 2.8 (0.7) 0.15

Abbreviations: SD, standard deviation; mm Hg, millimeters mercury; mg/dL; milligrams per deciliter; mmol/L, millimoles per liter; g/dL, grams per deciliter.

a

Data are presented as number (%) unless otherwise specified.

b

Current or within the last 30 days.

c

These data were only available for 81 patients.